Quinacrine analog 34

Quinacrine analog 34 is a derivative of the anti-protozoal agent quinacrine, redesigned as a less cytotoxic autophagy inhibitor. At concentrations as low as 0.5 μM, it increases LC3-II protein levels and induces lysosome deacidification, making it a useful research tool for studying autophagy mechanisms in cellular models.